Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christopher Marks is active.

Publication


Featured researches published by Christopher Marks.


Colorectal Disease | 2009

The uptake of laparoscopic colorectal surgery in Great Britain and Ireland: a questionnaire survey of consultant members of the ACPGBI

K. Schwab; H. M. Dowson; J. Van Dellen; Christopher Marks; T. A. Rockall

Objective  The National Institute for Clinical Excellence (NICE) has recommended laparoscopic resection as an alternative to open surgery for patients with colorectal cancer. The aim of this study was to evaluate the current uptake of laparoscopic colorectal surgery in Great Britain and Ireland.


Digestive Diseases and Sciences | 1996

An unusual presentation of intestinal duplication with a literature review.

Mark I. Otter; Christopher Marks; Martin G. Cook

A 52-year-old male presented with urinary symptoms of frequency and hesitation. X-rays, ultrasound, and computerized tomography investigations were performed that indicated the diagnosis and position of an enteric duplication cyst. Elective surgery was performed to completely remove the duplication cyst. Histological examination showed that the cyst was lined by stratified squamous, ciliated, and gastric-type epithelium, with a muscularis mucosae and a muscularis Propria. No malignancy or dysplasia was seen. Duplications of the alimentary tract are uncommon congenital abnormalities. They may be multiple and arise at any level from the mouth to the anus. Usually observed early in life, a minority may remain unsuspected until adulthood. The clinical presentations may be vague and diverse depending on their location. These include pain, distention, dysphagia, dyspepsia, and complications involve bleeding, perforation, malignancy, and obstruction of the alimentary tract and vessels. Plain x-rays are of limited use in the diagnosis of duplications but ultrasound findings may be diagnostic, with computerized tomography useful in delineating surrounding structures. Once the diagnosis is established, surgical correction is the treatment of choice, preferably with complete removal.


Cancers | 2011

Predictive and prognostic factors in colorectal cancer: a personalized approach.

Myutan Kulendran; John F. Stebbing; Christopher Marks; Timothy A. Rockall

It is an exciting time for all those engaged in the treatment of colorectal cancer. The advent of new therapies presents the opportunity for a personalized approach to the patient. This approach considers the complex genetic mechanisms involved in tumorigenesis in addition to classical clinicopathological staging. The potential predictive and prognostic biomarkers which have stemmed from the study of the genetic basis of colorectal cancer and therapeutics are discussed with a focus on mismatch repair status, KRAS, BRAF, 18qLOH, CIMP and TGF-β.


Colorectal Disease | 2006

Curative resection for low rectal adenocarcinoma: abdomino‐perineal vs anterior resection

A. C. Okaro; T. Worthington; J. F. Stebbing; Mary Broughton; S. Caffarey; Christopher Marks

Objective  Local recurrence after abdomino‐perineal excision of the rectum for tumours has been reported to occur in up to a third of patients in contrast to 4% after restorative anterior resection.


International Journal of Oncology | 2005

Coexpression, prognostic significance and predictive value of EGFR, EGFRvIII and phosphorylated EGFR in colorectal cancer

Matthew P. Cunningham; Sharadah Essapen; Hilary Thomas; Margaret Green; David P. Lovell; Clare Topham; Christopher Marks; Helmout Modjtahedi


British Journal of Surgery | 1995

A 10-year prospective audit of outcome of surgical treatment for colorectal carcinoma.

S. Singh; M. B. F. Morgan; Mary Broughton; S. M. Caffarey; C. Topham; Christopher Marks


International Journal of Oncology | 2006

Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients

Matthew P. Cunningham; Sharadah Essapen; Hilary Thomas; Margaret Green; David P. Lovell; Clare Topham; Christopher Marks; Helmout Modjtahedi


European Journal of Cancer Care | 2006

Risk of colorectal cancer in general practice patients presenting with rectal bleeding, change in bowel habit or anaemia.

Ross Lawrenson; John Logie; Christopher Marks


International Journal of Oncology | 2004

The expression and prognostic significance of HER-2 in colorectal cancer and its relationship with clinicopathological parameters.

Sharadah Essapen; Hilary Thomas; Margaret Green; Corrine De Vries; Martin G. Cook; Christopher Marks; Clare Topham; Helmout Modjtahedi


International Journal of Oncology | 1992

Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells

Matthew P. Cunningham; Hilary Thomas; Christopher Marks; Margaret Green; Zhen Fan; Helmout Modjtahedi

Collaboration


Dive into the Christopher Marks's collaboration.

Top Co-Authors

Avatar

Mary Broughton

Royal Surrey County Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hilary Thomas

University of Hertfordshire

View shared research outputs
Top Co-Authors

Avatar

Margaret Green

Royal Surrey County Hospital

View shared research outputs
Top Co-Authors

Avatar

S. M. Caffarey

Royal Surrey County Hospital

View shared research outputs
Top Co-Authors

Avatar

Sharadah Essapen

Royal Surrey County Hospital

View shared research outputs
Top Co-Authors

Avatar

Martin G. Cook

Royal Surrey County Hospital

View shared research outputs
Top Co-Authors

Avatar

A. C. Okaro

Royal Surrey County Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

B. Bekdash

Royal Surrey County Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge